microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells

BACKGROUND: MicroRNAs (miRNAs) are non-coding, single-stranded small RNAs that regulate gene expression negatively, which is involved in fundamental cellular processes. In this study, we investigated the role of miR-490-3P in the development of drug resistance in ovarian cancer cells. METHODS: The human ovarian carcinoma cell line A2780 and A2780/Taxol were exposed to paclitaxel in the presence or absence of microRNA 490-3P transfection, after which cell viability were performed by CCK-8 assay. Reverse transcription polymerase chain reaction (RT-PCR) and western blotting were used to assess the mRNA and protein expression levels of GST-π, MDR1 or P-gp. RESULTS: Our results showed higher miR-490-3P mRNA expression level in A2780/Taxol cells than in A2780 cells (p < 0.05). Following miR-490-3P transfection, both A2780 and A2780/Taxol cells showed decreased sensitivity to paclitaxel. The mRNA expression levels of MDR1, GST-π (p < 0.05) and protein expression levels of P-gp, GST-π were down-regulated after miR-490-3P transfection in comparison to mock and negative control cancer cells. CONCLUSION: Our results demonstrate for the first time that microRNA 490-3P may be involved in the development of drug resistance in ovarian cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13048-014-0084-4) contains supplementary material, which is available to authorized users

An Image Filter Based on Multiobjective Genetic Algorithm and Shearlet Transformation

Rician noise pollutes magnetic resonance imaging (MRI) data, making data’s postprocessing difficult. In order to remove this noise and avoid loss of details as much as possible, we proposed a filter algorithm using both multiobjective genetic algorithm (MOGA) and Shearlet transformation. Firstly, the multiscale wavelet decomposition is applied to the target image. Secondly, the MOGA target function is constructed by evaluation methods, such as signal-to-noise ratio (SNR) and mean square error (MSE). Thirdly, MOGA is used with optimal coefficients of Shearlet wavelet threshold value in a different scale and a different orientation. Finally, the noise-free image could be obtained through inverse wavelet transform. At the end of the paper, experimental results show that this proposed algorithm eliminates Rician noise more effectively and yields better peak signal-to-noise ratio (PSNR) gains compared with other traditional filters

Protective effects of 17β-estradiol on high glucose-induced RPE cells

AIM: To discuss the protective effects and possible mechanisms of 17β-estradiol on human retinal pigment epithelial(RPE)cells induced by high glucose. METHODS: RPE cells were cultured and divided into four groups according to randomized controlled method: blank control group: the cells were treated with 5.5mmol/L routine glucose medium for processing; high glucose group: cells were treated with 100mmol/L glucose for 12h; 17β-estradiol low concentration group: after treated with 10 μmol/L 17β-estradiol, cells were treated with 100mmol/L glucose for 12h; 17β-estradiol high concentration group: after treated with 100 μmol/L 17β-estradiol, cells were treated with 100mmol/L glucose for 12h. Cell viability were tested by MTT colorimetric detection. Cells apoptosis were detected by Hochest33258 staining. Intracellular reactive oxygen species(ROS)level were detected by H2DCFDA staining. Expression of CAT, SOD and MDA were tested by colorimetric detection. RESULTS: RPE cell activity decreased with the concentration of glucose increased; 17β-estradiol inhibited high glucose-induced cell viability decrease in RPE cells, decreased the apoptosis rate of RPE cells and intracellular ROS generation; besides, 17β-estradiol significantly increased the expression of CAT, SOD and decreased the expression of MDA in RPE cells. CONCLUSION: The 17β-estradiol effectively inhibited high glucose -induced RPE cells damage, which provide reliable experimental basis for the treatment of injuries in RPE cells

A novel Fas-binding outer membrane protein and lipopolysaccharide of Leptospira interrogans induce macrophage apoptosis through the Fas/FasL-caspase-8/-3 pathway.

Leptospira interrogans is the major causative agent of leptospirosis, an emerging, globally spreading zoonotic infectious disease. The pathogen induces macrophage apoptosis, but the molecular basis and mechanism remain unknown. In the present study, we found that L. interrogans caused apoptosis of phagocytosis-inhibited macrophages, and the product of the L. interrogans LB047 gene (Lep-OMP047) was the unique protein captured by mouse and human Fas proteins. The recombinant expressed Lep-OMP047 (rLep-OMP047) strongly bound mouse and human Fas proteins with equilibrium association constant (

LncRNA PCGEM1 Induces Ovarian Carcinoma Tumorigenesis and Progression Through RhoA Pathway

Background/Aims: Prostate cancer gene expression marker 1 (PCGEM1) is a long noncoding RNA (lncRNA) and is well known as a promoter in prostate cancer and osteoarthritis synoviocytes. However, the role PCGEM1 plays in epithelial ovarian cancer is unknown. Methods: PCGEM1 expression was examined in epithelial ovarian cancer and normal ovarian tissues using reverse transcription–PCR. Ovarian cancer cell phenotypes and genotypes were examined after PCGEM1 overexpression or downregulation in vitro; besides, the effects of PCGEM1 overexpression was also examined in vivo. Results: PCGEM1 expression level was higher in epithelial ovarian cancer tissues than in normal ovarian tissues and was positively associated with differentiation (Well vs. Mod/Poor). Upregulation of PCGEM1 induced cancer cell proliferation, migration, and invasion, but decreased cell apoptosis through upregulating RhoA, YAP (Yes-associated protein), MMP2 (matrix metalloproteinase 2), Bcl-xL, and P70S6K expression; while PCGEM1 downregulation had the opposite effect. The nude mouse xenograft assay demonstrated that PCGEM1 overexpression promoted tumor growth. Furthermore, silencing RhoA expression reversed the effect of PCGEM1 and significantly inhibited RhoA, YAP, MMP2, Bcl-xL, and P70S6K protein expression. Conclusion: In conclusion, we suggest that PCGEM1 may be an inducer in epithelial ovarian cancer tumorigenesis and progression by upregulating RhoA and the subsequent expression of YAP, P70S6K, MMP2, and Bcl-xL

Assessment of geothermal resource potential in Changbaishan utilizing high-precision gravity-based man-machine interactive inversion technology

As one of the clean energy sources, geothermal resources have no negative impact in changing the climate. However, the accurate assessment and precise identification of the potential geothermal resource is still complex and dynamic. In this paper, ~2,000 large-scale high-precision gravity survey points are conducted in the north of the Tianchi caldera, Changbaishan. Advanced data processing technologies can provide straightforward information on deep geothermal resources (Hot source, caprock, geothermal reservoir and geothermal migration pathway). Upwards continuation and the technologies decode two dome shaped low and gentle anomalies (−48 × 10−5 m/s2−65 m/s2) and a positive gravity gradient anomaly (0.4 × 10−7 m/s2−1.6 × 10−5 m/s2) in large-scale high-precision gravity planar. According to two point five dimensional man-machine interactive inversion technology and the research on petrophysical parameters, the density of the shied-forming basalts in the two orthogonal gravity sections is 2.58 g/cm3. The relatively intermediate to high density (2.60–2.75 g/cm3) represents geothermal reservoir, and low density (low to 2.58 g/cm3) is the geothermal migration pathway. In addition, large-scale high-precision gravity planar with a solution of about 1/50,000 indicate that the north of the Tianchi caldera exits the sedimentary basin and uplift mountain geothermal system

Comparison of two different starting dose of rhFSH in GnRH antagonist protocol for patients with normal ovarian reserve

ObjectiveTo evaluate different starting doses of recombinant human follicle-stimulating hormone (rhFSH) on pregnancy outcomes for patients with normal ovarian reserve during gonadotropin- releasing hormone antagonist (GnRH-ant) protocol-controlled ovarian stimulation of in vitro fertilization (IVF) cycles.MethodsIn this retrospective study, a total of 1138 patients undergoing IVF cycles following the GnRH-ant protocol were enrolled. Patients were divided into two groups according to the starting dose of rhFSH. 617 patients received a starting dose of rhFSH of 150 IU, and 521 patients received a starting dose of rhFSH of 225 IU. We compared demographic characteristics, ovarian stimulation and embryological characteristics, and pregnancy and birth outcomes between the two groups. Multivariate logistic regression analysis was performed to examine the possible effects of the known potential confounding factors on pregnancy outcomes.ResultsThe number of oocytes retrieved in the 150 IU rhFSH group was significantly lower than those in the 225 IU rhFSH group. There was no significant difference between the two groups referring to embryological characteristics. The proportion of fresh embryo transfer in the 150 IU rhFSH group was significantly higher than that in the 225 IU rhFSH group (48.30% vs. 40.90%), and there was no difference in the risk of ovarian hyperstimulation syndrome and pregnancy outcomes between the two groups.ConclusionsIn conclusion, the starting dose of rhFSH of 150 IU for ovarian stimulation has a similar pregnancy outcome as starting dose of rhFSH of 225 IU in GnRH-ant protocol for patients with normal ovarian reserve. Considering the potential cost-effectiveness and shorter time to live birth, the starting dose of rhFSH of 150 IU may be more suitable than 225 IU